AptarGroup, Inc. (N:ATR)

Business Focus: Plastic Container & Packaging

Get the company report for the most recent outlook updated daily

Apr 11, 2024 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.41 per share. The payment date is May 16, 2024, to stockholders of record as of April 25, 2024.

Mar 20, 2024 05:00 pm ET

Aptar Named a CDP Supplier Engagement Leader for the Fourth Consecutive Year

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, was named to the CDP Supplier Engagement Leaderboard, for the fourth consecutive year. Aptar is among over 450 companies that have made it onto CDP’s most recent Supplier Engagement Leaderboard based on its 2023 CDP disclosure and was cited for its contributions to emissions reductions throughout the value chain.

Feb 29, 2024 05:00 pm ET

Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Sixth Consecutive Year

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been named one of Barron’s 100 Most Sustainable U.S. Companies for the sixth consecutive year and is ranked number 29 out

Feb 09, 2024 10:00 am ET

Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions

Aptar Digital Health, part of AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has entered into an enterprise agreement with Biogen Inc. (Nasdaq: BIIB) to operate and develop digital health solutions for neurological and rare diseases. As part of the agreement, Biogen will transfer ownership of select digital health solutions to Aptar Digital Health (Aptar).

Feb 08, 2024 05:00 pm ET

Aptar Reports Fourth Quarter and Annual 2023 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong fourth quarter operational results driven by double-digit growth of the company’s proprietary drug delivery systems and strong growth for fragrance dispensing technologies. Reported sales increased by 5% and core sales, excluding currency and acquisition effects, increased by 2%. Aptar reported net income of $62 million for the quarter, a 6% increase over the prior year.

Jan 23, 2024 05:00 pm ET

Aptar Named One of America’s Most Responsible Companies by Newsweek for the Fifth Consecutive Year

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of America’s Most Responsible Companies 2024 by Newsweek for the fifth consecutive year. A

Jan 18, 2024 05:00 pm ET

Aptar Declares Quarterly Dividend and Announces 2024 Annual Meeting Details

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.41 per share. The payment date is February 22, 2024, to stockholders of record as of February 1, 2024.

Jan 04, 2024 05:00 pm ET

Aptar to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced their participation at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024.

Jan 02, 2024 05:00 pm ET

Aptar Announces 2024 Quarterly Conference Call Dates

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.

Dec 04, 2023 08:30 am ET

Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, is announcing a contract with the U.S. Food and Drug Administration (FDA) to study the challenges with developing low Global Warming Potential (low-GWP) propellant metered dose inhalers (MDIs).

Nov 01, 2023 05:00 pm ET

Aptar Named Among Top 15 of the ‘World’s Top Companies for Women 2023’ by Forbes

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named a World’s Top Companies for Women 2023 by Forbes for the third consecutive year (formerly World’s Top

Oct 25, 2023 05:00 pm ET

Aptar Reports Third Quarter 2023 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong operational performance driven by continued growth of the company’s proprietary drug delivery systems. Strong sales from prestige and mass fragrance dispensing devices also contributed positively to the results. Reported sales increased by 7% and core sales, excluding currency and acquisition effects, increased by 2%. Aptar reported net income of $84 million for the quarter, a 55% increase over the prior year.

Oct 18, 2023 05:00 pm ET

Aptar Named Among the 100 Best Corporate Citizens for Third Consecutive Year

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named to 3BL Media’s 100 Best Corporate Citizens list for the third consecutive year in a row for environmental, social and governance (ESG) transparency an

Oct 12, 2023 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.41 per share. The payment date is November 16, 2023, to stockholders of record as of October 26, 2023.

Sep 05, 2023 05:00 pm ET

Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors.

Aug 24, 2023 08:30 am ET

Aptar Announces 2023 Investor Day

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, will host an Investor Day on Friday, September 8, 2023. The event will begin at 10:00 a.m. EDT. Presentations by members of executive management followed by a moderated Q&A session are expected to conclude at approximately 12:15 p.m. EDT.

Jul 27, 2023 05:00 pm ET

Aptar Reports Second Quarter 2023 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong operational performance driven by continued growth of the company’s proprietary drug delivery systems and significant sequential improvement in injectables sales as Enterprise Resource Planning (ERP) system implementation effects moderated. Strong sales from prestige and mass fragrance also contributed positively to the results. Reported sales increased by 6% and core sales, excluding currency and acquisition effects, increased by 4%. Aptar reported ne

Jul 13, 2023 05:00 pm ET

Aptar Announces Quarterly Dividend Increase of 7.9%

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.41 per share, an almost 8% increase from the previous dividend amount, bringing the new annualized dividend to $1.64 per share. The payment date is August 17, 2023, to stockholders of record as of July 27, 2023.

Jun 26, 2023 12:00 pm ET

Aptar Mourns Passing of Ervin J. LeCoque, First CEO and Board Chairman as a Publicly Traded Company

AptarGroup, Inc. (NYSE: ATR), today announced with great sadness that Ervin “Erv” J. LeCoque, the first Chief Executive Officer and Chairman of the Board when Aptar became a publicly traded company, has passed away.

May 30, 2023 05:00 pm ET

Aptar Releases 2022 Corporate Sustainability / ESG Report

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today released its 2022 Corporate Sustainability / ESG Report entitled Purpose Takes Shape. Aptar’s 2022 Corporate Sustainabili

May 24, 2023 05:00 pm ET

Aptar Named One of America’s Climate Leaders by USA Today

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, was named one of America’s Climate Lea

Apr 28, 2023 08:00 am ET

Candace Matthews Elected Independent Chairperson of Aptar’s Board of Directors

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced that Candace Matthews has been elected independent chairperson of the company’s Board of Directors, effective immediately following the company’s 2023 annual meeting of stockholders on May 3, 2023. Candace will succeed George Fotiades, who will remain on the Board of Directors.

Apr 27, 2023 05:00 pm ET

Aptar Reports First Quarter 2023 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported strong operational performance driven by Aptar’s Pharma and Beauty segments. Reported sales increased by 2% and core sales, excluding currency and acquisition effects, increased 4%. Aptar reported net income of $55 million for the quarter, a 12% decrease over the prior year, primarily due to restructuring charges.

Apr 20, 2023 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is May 25, 2023, to stockholders of record as of May 4, 2023.

Apr 13, 2023 05:00 pm ET

Aptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has issued financial information recast for the previously announced strategic segmen

Mar 23, 2023 05:00 pm ET

Aptar Named a CDP Supplier Engagement Leader for the Third Consecutive Year

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, was named to the CDP Supplier Engagement Leaderboard for the third consecutive year. Aptar is among the top 8% assessed for supplier engagement on climate change, based on its 2022 CDP disclosure, and was cited for its contributions to emissions reductions throughout the value chain.

Mar 15, 2023 05:00 pm ET

Aptar Surpasses Emissions Reduction Goals and Issues Updated Science-Based Targets in Line with 1.5°C Climate Ambition

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that it has updated its Scope 1 and 2 science-based targets, setting an emissions reduction goal consistent with requirements to limit global temperature rise to 1.5° Celsius by year 2030.

Mar 08, 2023 05:00 pm ET

Aptar Named One of Barron’s 100 Most Sustainable Companies in the U.S. for the Fifth Consecutive Year

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has been named one of Barron’s

Mar 01, 2023 05:00 pm ET

Aptar Appoints Julie Xing to its Board of Directors

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that Julie Xing has joined its Board of Directors.

Feb 16, 2023 05:00 pm ET

Aptar Reports Fourth Quarter and Annual 2022 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported net income of $59 million for the quarter ended December 31, 2022, a 2% increase over the prior year. Reported sales decreased 2% and core sales, excluding currency and acquisition effects, increased by 4% over the prior year.

Feb 13, 2023 05:00 pm ET

Aptar Again Receives Platinum Rating from EcoVadis

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has again achieved the Platinum level rating in recognition of its sustainability efforts from EcoVadis. The Platinum rating places Aptar among the top 1% of the more than 90,000 companies rated by EcoVadis across all industries.

Jan 30, 2023 08:50 am ET

Aptar Pharma Launches First Metal-Free Nasal Spray Pump, Meeting Growing Need for Highly Recyclable Packaging

Aptar Pharma, part of AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery systems, services and active material science solutions, today announces the launch of APF Futurity, its first metal-free, multidose nasal spray pump developed to deliver nasal saline and other comparable over-the-counter (OTC) formulations.

Jan 19, 2023 05:00 pm ET

Aptar Declares Quarterly Dividend and Announces 2023 Annual Meeting Details

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is February 23, 2023, to stockholders of record as of February 2, 2023.

Jan 04, 2023 05:00 pm ET

Aptar Announces 2023 Quarterly Conference Call Dates

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.

Dec 21, 2022 05:00 pm ET

Aptar to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced their participation at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023.

Dec 15, 2022 05:00 pm ET

Aptar in Top 15 of America’s Most Responsible Companies 2023 by Newsweek

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has been named one of America’s Most Responsible Companies 2023 by Newsweek and is ranked #15 out of 500 U.S. co

Dec 12, 2022 05:00 pm ET

Aptar Announces the Realignment of Two of its Business Reporting Segments

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced that it will realign two of its business reporting segments effective January 1, 2023. Aptar’s two renamed reporting segments will be Aptar Closures and Aptar Beauty. The new segment structure is designed to streamline operations, improve efficiencies and enable a stronger customer focus across all closure applications.

Nov 02, 2022 05:00 pm ET

Aptar Again Named a Global Top Female-Friendly Company by Forbes

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced it has again been named one of the World’s Top Female-Friendly Companies by Forbes. Aptar is rank

Oct 27, 2022 05:00 pm ET

Aptar Reports Third Quarter 2022 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported net income of $54 million for the quarter ended September 30, 2022, a 15% increase over the prior year. Reported sales grew 1% and core sales, excluding currency and acquisition effects, increased by 9% over the prior year.

Oct 18, 2022 08:30 am ET

Aptar and Chiesi Sign Digital Health Contract to bring Best-in-Class Disease Management Platform for Patients with Asthma and COPD

Aptar Digital Health, part of Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced a strategic partnership with the Chiesi Group, the international research-focused biopharmaceutical and healthcare group, to bring to market a disease management platform for asthma and chronic obstructive pulmonary disease (COPD). Aptar Digital Health is a division of Aptar Pharma, part of Aptar (NYSE:ATR).

Oct 13, 2022 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is November 16, 2022, to stockholders of record as of October 26, 2022.

Sep 22, 2022 08:30 am ET

Aptar Expands Pharmaceutical Services; Announces Exclusive Collaboration Between Aptar Pharma and Fluidda

Nanopharm, an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products (OINDPs), today announced an exclusive collaboration with Fluidda, a leader in the field of Functional Respiratory Imaging. The companies will leverage their respective proprietary technology platforms to help accelerate U.S. Food & Drug Administration (FDA) approvals for orally inhaled generic products (OIDPs) via the alternative bioequivalence pathway. Nanopharm was acquired by Aptar (NYSE: ATR) in 2019, as part of the company’s strategy to expand its service

Sep 12, 2022 05:00 pm ET

Aptar Appoints Matthew L. Trerotola to its Board of Directors

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that Matt Trerotola has joined its Board of Directors.

Jul 28, 2022 05:00 pm ET

Aptar Reports Second Quarter 2022 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported net income of $64 million for the quarter ended June 30, 2022, a 15% increase over the prior year. Reported sales grew 4% and core sales increased by 10% over the prior year.

Jul 13, 2022 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is August 17, 2022, to stockholders of record as of July 27, 2022.

Jun 22, 2022 05:00 pm ET

Aptar Releases 2021 Corporate Sustainability / ESG Report

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today released its 2021 Corporate Sustainability / ESG Report entitled Better Takes Shape. Aptar’s 2021 Corpo

May 18, 2022 05:00 pm ET

Aptar Named Among the 100 Best Corporate Citizens for 2022

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that it has been named to 3BL Media’s 100 Best Corporate Citizens ranking for the second year in a row for environmental, social and governance (ESG) tr

Apr 28, 2022 05:00 pm ET

Aptar Reports First Quarter 2022 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported first quarter results for 2022.

Apr 14, 2022 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is May 18, 2022, to stockholders of record as of April 27, 2022.

Apr 11, 2022 08:30 am ET

Aptar Announces Passing of Director Jesse Wu

AptarGroup, Inc. (NYSE: ATR) today announced with deep sadness that Jesse Wu, a director of the Company, has passed away. Mr. Wu served on the Board of Directors since 2018 and was a member of the Management Development & Compensation Committee.

Mar 02, 2022 09:04 pm ET

AptarGroup, Inc. Announces Pricing of $400 Million of 3.600% Senior Notes due 2032

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced the pricing of an underwritten public offering of $400 million aggregate principal amount of its 3.600% Senior Notes due 2032. Closing of the offering is expected to occur on March 7, 2022, subject to the satisfaction of customary closing conditions. Aptar intends to use the net proceeds from the offering to repay amounts outstanding under its revolving credit facility, and the remainder for general corporate purposes, which may include

Feb 21, 2022 05:00 pm ET

Aptar Named One of Barron’s 100 Most Sustainable Companies in the U.S. for the Fourth Consecutive Year

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, has again been named one of Barron’s 100 Most Sustainable Companies. Aptar is ranked number 70 for 2022 and this marks the fourth

Feb 17, 2022 05:00 pm ET

Aptar Reports Fourth Quarter and Annual 2021 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported fourth quarter and annual results for 2021.

Jan 31, 2022 08:30 am ET

Aptar Receives Platinum Rating from EcoVadis

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, has received the Platinum level rating in recognition of its sustainability efforts from EcoVadis. The Platinum rating places Aptar among the top 1% of the nearly 85,000 companies rated by EcoVadis across all industries.

Jan 20, 2022 05:00 pm ET

Aptar Declares Quarterly Dividend and Announces 2022 Annual Meeting Details

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash dividend of $0.38 per share. The payment date is February 23, 2022, to stockholders of record as of February 3, 2022.

Jan 04, 2022 05:00 pm ET

Aptar Announces 2022 Quarterly Conference Call Dates

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.

Dec 02, 2021 03:09 pm ET

Aptar in Top 10 of America’s Most Responsible Companies 2022 by Newsweek

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material solutions, has been named one of America’s Most Responsible Companies 2022 by Newsweek and is ranked #10 out of 500 U.S. companies. Aptar is also ranked fi

Nov 30, 2021 08:30 am ET

Aptar Named One of the Most Responsible Companies in France by Le Point

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material solutions is named one of the Most Responsible Companies in France for 2022 by Le Point. Aptar ranks in the top 100 companies for its efforts in the areas of Environment, Social and Governance (ESG).

Nov 18, 2021 05:19 pm ET

Aptar Tops the Forbes Green Growth 50 List

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material solutions, announced today that it has been ranked #1 on Forbes’ Green Growth 50 2021 inaugural list. As part of the Green Growth 50, Forbes is highlighting large America

Nov 02, 2021 04:05 pm ET

Aptar Named a Global Top 10 Female-Friendly Company by Forbes

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material solutions, is named one of the World’s Top Female-Friendly Companies 2021 by Forbes. Aptar is ranked in the top ten and is number eight out of the 300 companies included for 2021. Forbes teamed with Statista to identify companies leading the way to support women inside and outside of their workforces, including making meaningful changes to address the burdens women have faced during the COVID-19 pandemic.

Oct 28, 2021 05:07 pm ET

Aptar Reports Third Quarter 2021 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today reported third quarter results for 2021.

Oct 25, 2021 08:30 am ET

First Nasally-Administered Pharmaceutical Treatment for Dry Eye Disease Approved by US FDA with Aptar’s Nasal Pump System

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today announced that its patented Cartridge Pump System (CPS), designed for the multidose delivery of preserved and non-preserved drug formulations, was recently reviewed by the U.S. FDA as the drug delivery device in the approval of Oyster Point Pharma’s TYRVAYA™ (varenicline solution) Nasal Spray 0.03 mg1, the first and only nasal spray approved for the treatment of the signs and symptoms of dry eye disease.

Oct 14, 2021 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash dividend of $0.38 per share. The payment date is November 17, 2021, to stockholders of record as of October 27, 2021.

Sep 09, 2021 02:09 pm ET

Aptar to Host Virtual Capital Markets Day

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, will host a virtual Capital Markets Day on Friday, September 10, 2021. The event will begin at 9:00 a.m. EDT. Senior executives from the company will speak and then answer questions from the audience. Interested parties can access the presentation slides and listen live by visiting the Investor Relations page at

Sep 07, 2021 01:21 pm ET

Aptar Mourns Death of Longtime Board Member, Dr. Joanne Smith

AptarGroup, Inc. (NYSE: ATR) today announced with great sadness that Dr. Joanne Smith, a valued longtime member of the Board of Directors, has passed away.

Sep 02, 2021 05:00 pm ET

Aptar Announces the Completion of the Acquisition of a Majority Stake in Voluntis

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced today that following the signature of a share purchase agreement on July 22, 2021 and the approval of the French Ministry of Economy under the foreign investment clearance regulations, it has completed the acquisition of a majority stake in Voluntis (ENXTPA: ALVTX) from the company's reference shareholders and certain members of the management. The stake acquisition represents approximately 64.6% of the share capital of Voluntis (on a non-diluted basis),

Jul 29, 2021 05:48 pm ET

Aptar Reports Second Quarter 2021 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today reported second quarter results for 2021.

Jul 28, 2021 05:00 pm ET

Aptar Enters into Agreement with Weihai Hengyu Medical Products to Add Elastomeric and Plastic Component Manufacturing Capabilities in China for Injectable Drug Delivery

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced today that it has entered into an agreement to acquire 80% of the equity interests of Weihai Hengyu Medical Products Co., Ltd., a leading Chinese manufacturer of elastomeric and plastic components used in injectable drug delivery.

Jul 23, 2021 05:00 pm ET

Aptar Announces the Signature of a Share Purchase Agreement Regarding the Acquisition of a Majority Stake in Voluntis at a Price of €8.70 Per Share

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions announced today that following the entry into exclusive negotiations with Voluntis (ENXTPA: ALVTX) on June 21, 2021, and after completion of the consultation procedure of the employee representative bodies of Voluntis, it has signed on July 22, 2021 a share purchase agreement for the acquisition of a majority stake in Voluntis, representing approximately 64.6% of the share capital of Voluntis (on a non-diluted basis), at a price of €8.70 per share.

Jul 22, 2021 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash dividend of $0.38 per share. The payment date is August 25, 2021, to stockholders of record as of August 4, 2021.

Jul 07, 2021 05:00 pm ET

Aptar Announces Strategic Collaboration with YAT, a Chinese Online Skincare Company, to Develop Range of Products and Services for the Skincare Market

Aptar will leverage YAT’s expansive market insight database, focused on specific consumer skincare needs and skincare profiles, and will use YAT’s in-depth experience in customized turnkey solutions as well as online product distribution and promotion to bring new solutions to market.

Jun 22, 2021 09:00 am ET

Aptar Announces Exclusive Negotiations Regarding a Potential Acquisition of Voluntis to Expand in Digital Therapeutics

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions announced today that it has entered into exclusive negotiations with respect to a potential acquisition of all outstanding shares of Voluntis (ENXTPA: ALVTX), a pioneer in digital therapeutics.

May 27, 2021 12:30 pm ET

Aptar Releases 2020 Corporate Sustainability Report

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today released its 2020 Corporate Sustainability Report. The 2020 Sustainability Report highlights Aptar’s extensive sustainability in

May 26, 2021 08:30 am ET

Aptar Introduces a Fully Recyclable Mono-Material Pump

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announces the launch of the company’s first fully recyclable mono-material pump for the beauty and personal care industries, called Future.

May 24, 2021 04:32 pm ET

Aptar Appoints Candace Matthews to the Board of Directors

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced today that Candace Matthews has joined its Board of Directors.

May 19, 2021 05:00 pm ET

Aptar Named Among the 100 Best Corporate Citizens of 2021

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced today that it has been named to 3BL Media’s 100 Best Corporate Citizens ranking for its leadership and transparency in environmental, social and governance (ESG). 3BL Medi

May 06, 2021 05:00 pm ET

Aptar Announces Price Increases

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced today that it will increase prices five percent for its beauty, personal care and home care products. The price increases will take effect June 1, 2021 and will be in addition to any price adjustments related to raw material cost increases. The price adjustments are necessary due to sustained significant cost inflation on non-raw material input costs including freight, energy and labor.

Apr 29, 2021 05:12 pm ET

Aptar Reports First Quarter 2021 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today reported first quarter results for 2021.

Apr 15, 2021 05:00 pm ET

Aptar Raises Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and material science solutions, today declared a quarterly cash dividend of $0.38 per share which is an increase of approximately 6% from the previous dividend amount. The payment date is May 19, 2021, to stockholders of record as of April 28, 2021.

Feb 24, 2021 05:00 pm ET

Aptar Named One of Barron’s 100 Most Sustainable Companies in the U.S. for the Third Consecutive Year

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material solutions, has again been named one of Barron’s 100 Most Sustainable Companies. Aptar is ranked number 76 for 2021 and this marks the third consecutive year Aptar has been included on Barron’s esteemed list.

Feb 18, 2021 05:00 pm ET

Aptar Reports Fourth Quarter and Annual 2020 Results; Showcases Resilient Business with Strong Second Half Results and Record Annual Free Cash Flow

AptarGroup, Inc. (NYSE:ATR) today reported fourth quarter and annual results for 2020 and highlighted the resiliency of the Company’s business model throughout the COVID-19 pandemic.

Feb 17, 2021 08:30 am ET

Aptar Partners with CARE to Further Women’s Economic Empowerment and Sponsors the Fast + Fair COVID-19 Vaccine Response Campaign

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has partnered with CARE®, a 501(c) organization who works around the globe to save lives, defeat poverty and achieve social justice. Through our on-going global partnership, Aptar will support CARE’s mission, including education programming, women’s economic empowerment efforts and CARE’s Crisis Response Campaign, by sponsoring the Fast + Fair COVID-19 Vaccine Response Campaign.

Feb 15, 2021 05:00 pm ET

Aptar’s Activ-Film™ Technology Selected to Protect New SARS Rapid Antigen Test for COVID-19 Diagnosis

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced that its Activ-Film™ technology was selected to protect a new SARS Rapid Antigen test for COVID-19 that recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).

Jan 14, 2021 05:00 pm ET

Aptar Declares Quarterly Dividend and Announces 2021 Annual Meeting Details

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash dividend of $0.36 per share. The payment date is February 17, 2021, to stockholders of record as of January 27, 2021.

Jan 12, 2021 04:19 pm ET

Aptar to Present at 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced their participation at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021.

Jan 06, 2021 05:00 pm ET

Aptar Promotes New Policies around Human Rights; Diversity, Equity and Inclusion; and Community Engagement and Global Giving

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has recently published new policies around Human Rights;

Jan 05, 2021 05:00 pm ET

Aptar Announces 2021 Quarterly Conference Call Dates

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.

Dec 15, 2020 08:30 am ET

Aptar Earns Prime Status from ISS ESG, a Leading Rating Agency for Sustainable Investments

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has recently been recognized with Prime status by ISS ESG, one of the world’s leading rating agencies for sustainable investments. The ISS ESG Corporate Rating considers Environmental, Social and Governance (“ESG”) practices by evaluating more than 100 industry specific indicators. Companies are categorized as Prime if their ESG performance exceeds the threshold criteria for companies in its sector. In comparison to non-Prime peers, these companies are considered better p

Dec 08, 2020 08:35 am ET

Aptar Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has been recognized for its leadership in corporate sustainability by the global environmental non-profit CDP, securing a place on its prestigious ‘A List’ for tackling climate change.

Dec 04, 2020 08:30 am ET

Aptar Named Among Top 100 of “America’s Most Responsible Companies 2021” by Newsweek

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has been named one of “America’s Most Responsible Companies 2021” by Newsweek and is ranked in the top 100 among 400 U.S. companies.

Dec 03, 2020 04:13 pm ET

Aptar Named One of the “Most Responsible Companies in France” by Le Point

AptarGroup, Inc. (NYSE:ATR) a global leader in drug delivery, consumer product dispensing and active packaging solutions, has been named one of the “Most Responsible Companies in France” by Le Point. Aptar ranks in the top 100 companies for its efforts in the areas of Environment, Social and Governance (ESG) and in the top 50 companies in the Environment category.

Oct 29, 2020 05:00 pm ET

Aptar Reports Third Quarter 2020 Results

AptarGroup, Inc. (NYSE:ATR) today reported third quarter results for 2020 and provided an update related to COVID-19 including the Company’s continued supply of essential products for critical industries.

Oct 15, 2020 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash dividend of $0.36 per share. The payment date is November 18, 2020, to stockholders of record as of October 28, 2020.

Aug 20, 2020 05:00 pm ET

Aptar’s Emission Reduction Goals Validated by Science Based Target Initiative (SBTi)

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, is proud to announce its science-based targets have been validated by the Science Based Targets initiative (SBTi).

Jul 30, 2020 05:00 pm ET

Aptar Reports Second Quarter 2020 Results

AptarGroup, Inc. (NYSE:ATR) today reported second quarter results for 2020 and provided an update related to COVID-19 including the Company’s ability to supply essential products for critical industries and continued health and safety measures being implemented across its global facilities.

Jul 16, 2020 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash dividend of $0.36 per share. The payment date is August 19, 2020, to stockholders of record as of July 29, 2020.

Jul 10, 2020 08:30 am ET

Aptar Appoints Kimberly Y. Chainey as EVP General Counsel

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced today that Kimberly Y. Chainey will join the company as its Executive Vice President, Global General Counsel, effective July 27, 2020. Chainey will be responsible for the company's global legal affairs and will become a member of Aptar’s Executive Committee.

Jun 17, 2020 05:00 pm ET

Aptar Releases 2019 Corporate Sustainability Report

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today released its 2019 Corporate Sustainability Report. The 2019 Sustainability Report highlights Aptar’s extensive sustainability initiatives that have been implemented across its global

Jun 03, 2020 05:00 pm ET

Aptar Joins United Nations Global Compact Initiative, Joining Forces with Global Companies and Organizations Focused on Human Rights, Labor, Environment and Anti-Corruption

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced that it has joined the United Nations (UN) Global Compact, the world’s largest citizenship initiative, which focuses on universal principles in the areas of human rights, labor, environment and anti-corruption.

May 08, 2020 08:30 am ET

Aptar Submits Application for Emergency Use Authorization to the German Regulatory Agency BfArM for ActivShield™ FFP2 Decontamination System

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, is seeking Emergency Use Authorization (EUA) from the German Federal Institute for Drugs and Medical Devices (BfArM) for a solution that allows for easy disinfecting of FFP2 filtering facepiece respirators (FFP2 masks). The FFP2 masks are desperately needed by healthcare personnel due to the global shortage of disposable masks during the COVID-19 pandemic.

Apr 30, 2020 05:04 pm ET

Aptar Reports First Quarter 2020 Results; Continues to Provide Essential Solutions to Critical Industries

AptarGroup, Inc. (NYSE:ATR) today reported first quarter results for 2020 and provided an update related to COVID-19 including the Company’s continued ability to supply essential solutions to critical industries.

Apr 21, 2020 05:00 pm ET

Aptar and Sonmol Partner to Develop Digital Platform for Respiratory-Related Therapies

AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions and services, and Sonmol, a leading Chinese digital respiratory therapeutics company, have announced a collaboration for developing a digital therapies and services platform targeting respiratory and other diseases.

Apr 15, 2020 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash dividend of $0.36 per share. The payment date is May 20, 2020, to stockholders of record as of April 29, 2020.

Apr 03, 2020 05:58 pm ET

Aptar Requests U.S. FDA Emergency Use Authorization for N95 Filtering Facepiece Respirator Decontamination with ActivShieldTM

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, is seeking U.S. FDA Emergency Use Authorization (EUA) for a solution that allows easy disinfecting of N95 filtering facepiece respirators (N95 mask). The N95 masks are desperately needed by healthcare personnel due to the shortage of disposable masks during the COVID-19 pandemic.

Feb 20, 2020 05:00 pm ET

Aptar Reports Fourth Quarter and Annual Results; Recaps Year of Pharma Services Acquisitions and Multiple New Drug Delivery Launches; Highlights Strategic Steps to Strengthen Beauty Business

AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions and services, today reported its fourth quarter and full year 2019 financial results.

Feb 18, 2020 08:30 am ET

Aptar Again Named One of Barron’s 100 Most Sustainable Companies in America

AptarGroup, Inc. (NYSE:ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, has again been named one of Barron’s 100 Most Sustainable Companies in America. Aptar is number 48 on the top 100 list for 2020 and this marks the second time Aptar has been included on the esteemed list.

Feb 14, 2020 08:30 am ET

Aptar to Acquire FusionPKG, A Leader in Turnkey Solutions for the Beauty Market

AptarGroup, Inc. (NYSE:ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, announced it has entered into a binding agreement to acquire Fusion Packaging I, L.P. (“FusionPKG”). FusionPKG is a leader in high quality, prestige airless and color cosmetics packaging, and conception-to-launch turnkey solutions for the North American beauty market.

Jan 31, 2020 02:00 pm ET

Aptar Named One of “America’s Most Responsible Companies 2020” by Newsweek

Jan 16, 2020 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash dividend of $0.36 per share. The payment date is February 19, 2020, to stockholders of record as of January 29, 2020.

Jan 02, 2020 05:00 pm ET

Aptar Announces Quarterly Conference Call and Annual Meeting Information

Dec 09, 2019 08:30 am ET

Aptar’s Nasal Unidose Device Approved by U.S. FDA for First Nasal Rescue Treatment for Frequent Seizure Activity

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today announced that its patented Unidose Liquid System is the device delivering the first and only nasal rescue treatment approved by the U.S. FDA, which has recently launched in the U.S. to treat acute repetitive seizures in people living with epilepsy. This ready-to-use rescue treatment can be used when and where a seizure cluster occurs thanks to Aptar’s proven, intuitive and convenient Unidose Liquid System.

Oct 31, 2019 05:00 pm ET

Aptar Reports Third Quarter Results; Acquires Noble International, a Leader in Drug Delivery Training Devices and Patient Onboarding; Announces Segment Leadership Appointments

AptarGroup, Inc. (NYSE:ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, today reported its third quarter 2019 financial results. In addition, Aptar has acquired Noble International (Noble), a leader in drug delivery training devices and patient onboarding and announced certain segment leadership appointments.

Oct 23, 2019 12:00 pm ET

Aptar Opens New Technical Education Center Focused on Training and Retaining Manufacturing Talent

AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, drug delivery and active packaging solutions, hosted a grand opening event for its new Technical Education Center (TEC) in Lincolnton, NC. This facility is part of Aptar’s Corporate Vocational University (CVU) training program and will provide both six and twelve month training opportunities for manufacturing roles. The program is intended to expand to other Aptar facilities and countries in the coming years.

Oct 22, 2019 05:00 pm ET

Aptar’s Activ-Blister™ Packaging Solution Approved by U.S. FDA for Oral Solid Dose HIV Prevention Medicine

AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, today announced that its Activ-Blister™ packaging solution for oral solid dose drug delivery was recently approved by the U.S. Food and Drug Administration (FDA) for a HIV prevention medicine.

Oct 21, 2019 09:30 am ET

Bryn Pharma Partners with Aptar Pharma for Nasal Epinephrine Treatment

RALEIGH, N.C., Oct. 21, 2019 /PRNewswire/ -- Bryn Pharma, LLC ("Bryn" or the "Company"), a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis, today announced that it has entered into an agreement with Aptar Pharma (AptarGroup NYSE: ATR), a leading drug delivery systems provider, for the supply and worldwide exclusive right to use Aptar's novel, FDA-approved Bidose (BDS) nasal device for the delivery of epinephrine to treat anaphylaxis.

Oct 17, 2019 05:00 pm ET

Aptar Declares Quarterly Dividend

The Board of Directors of AptarGroup, Inc. (NYSE: ATR) today declared a quarterly cash dividend of $0.36 per share. The payment date is November 20, 2019, to stockholders of record as of October 30, 2019.

Oct 09, 2019 05:00 pm ET

Aptar Joins Catalyst CEO Champions For Change to Accelerate the Progress and Representation of Women in its Global Workforce

AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing, sealing and active packaging solutions, announced today that it has joined the Catalyst CEO Champions For Change. With a strong commitment from Aptar’s President and CEO, Stephan Tanda, the company is focused on furthering gender equality, diversity, and inclusion in the workplace.

Oct 07, 2019 05:00 pm ET

Aptar to Acquire a Strategic Equity Interest in BTY, a Leading Chinese Color Cosmetics Packaging Manufacturer

AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing, drug delivery and active packaging solutions, announced today that it has signed an agreement to acquire a 49% equity interest in three related BTY companies: Suzhou Hsing Kwang (“SZHK”), Suqian Hsing Kwang (“SQHK”) and Suzhou BTY (“BTY”), collectively referred to as BTY. The BTY entities are leading Chinese manufacturers of high quality, decorative metal components, metal-plastic sub-assemblies and complete color cosmetics packaging solutions for the beauty industry.

Sep 10, 2019 07:30 am ET

Biohaven Advances NOJECTION™ Migraine Platform With Completion Of Enrollment Of Pivotal Phase 2/3 Trial Of Vazegepant, The First Intranasally Administered CGRP Receptor Antagonist In Development For T

NEW HAVEN, Conn., Sept. 10, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a biotechnology company focused on advancing innovative therapies for neurological and neuropsychiatric diseases, today announced completion of enrollment in its Phase 2/3, double-blind, randomized, placebo-controlled, dose-ranging trial of intranasally administered vazegepant (formerly BHV-3500) for the acute treatment of migraine. Vazegepant is a novel, structurally unique, third-generation calcitonin gene-related peptide (CGRP) receptor antagonist and the second product candidate in

Sep 03, 2019 05:00 pm ET

Aptar Enters into Strategic Partnership with PureCycle to Accelerate Integration of Ultra-Pure Recycled Polypropylene into Dispensing Solutions

AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing, drug delivery and active packaging solutions, announced today that it has partnered with PureCycle Technologies, to prepare for the introduction of PureCycle’s Ultra-Pure Recycled Polypropylene (UPRP) into dispensing applications.

Aug 29, 2019 05:00 pm ET

Aptar Announces Partnership with TerraCycle’s Loop Platform

AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing, drug delivery and active packaging solutions, announced today that the company has entered into a partnership with Loop, a global circular shopping platform from TerraCycle that delivers consumer products in reusable containers. As part of the partnership agreement, Aptar’s President of Food + Beverage, Marc Prieur, will sit on Loop’s advisory board.

Aug 26, 2019 11:00 am ET

Aptar Partners with Nippon Closures to Provide Innovative Tethered Beverage Closure Solutions

AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing, drug delivery and active packaging solutions, and Nippon Closures Co., Ltd. (NCC), a leading company in Japan for bottle closures, announced today that they have entered into an exclusive partnership to cross-license technology for tethered beverage closures. This is the first cross-license, registered intellectual property exchange between NCC and Aptar. The companies intend to expand this exchange into other areas as well.

Aug 22, 2019 05:00 pm ET

Aptar Announces Capital Markets Day and Confirms Third Quarter Conference Call Date

AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing, drug delivery and active packaging solutions, announced today that the company will host its Capital Markets Day in New York City, on Thursday, September 5, 2019. The event will begin at 8:00 a.m. EDT. Senior executives from the company will speak and then answer questions from the audience. Interested parties can access the presentation slides and listen live by visiting the Investor Relations page at

Jul 31, 2019 05:00 pm ET

Aptar Reports Second Quarter Results

AptarGroup, Inc. (NYSE:ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, today reported second quarter 2019 financial results.

Jul 25, 2019 10:31 am ET

Aptar’s Nasal Unidose Device Approved by US FDA for First Needle-Free Rescue Treatment for Severe Hypoglycemia

AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing and drug delivery solutions, today announced that its Unidose Powder System was recently approved by the U.S. Food and Drug Administration (FDA) for an intranasal, needle-free rescue treatment drug intended to treat severe hypoglycemia in people with diabetes. This marks the first FDA approval of a prescription drug using Aptar’s patented Unidose Powder System and is Aptar’s first combination of a drug delivery device with a protective active packaging container.

Jul 17, 2019 05:00 pm ET

Aptar Declares Quarterly Dividend

The Board of Directors of AptarGroup, Inc. (NYSE: ATR) today declared a quarterly cash dividend of $0.36 per share. The payment date is August 21, 2019, to stockholders of record as of July 31, 2019.

Jun 11, 2019 05:06 pm ET

Aptar Acquires Nanopharm and Gateway Analytical, Broadening Pharma Services Platform to Accelerate Customer Drug Development

AptarGroup, Inc. (NYSE: ATR) today announced that it has acquired two leading pharmaceutical services companies, Nanopharm Ltd. and Gateway Analytical LLC, for a combined enterprise value of approximately $50 million. The acquisitions are part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments.

May 30, 2019 05:00 pm ET

Aptar Releases Corporate Sustainability Report

AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing, sealing and active packaging solutions, today released its 2018 Corporate Sustainability Report. The 2018 Sustainability Report highlights the robust sustainability initiatives that have been

May 23, 2019 05:00 pm ET

Aptar Joins the Ellen MacArthur Foundation’s CE100 Circular Economy Network

AptarGroup, Inc. (NYSE: ATR) announced today that it has joined the Ellen MacArthur Foundation’s Circular Economy 100 (CE100), the world’s leading circular economy network.

May 01, 2019 03:13 pm ET

Aptar Announces the Appointment of Isabel Marey-Semper to the Board of Directors

AptarGroup, Inc. (NYSE:ATR), announced today that Isabel Marey-Semper has joined Aptar’s Board of Directors.

Apr 30, 2019 05:00 pm ET

Aptar Reports First Quarter Results

AptarGroup, Inc. (NYSE:ATR) today reported first quarter results for 2019.

Apr 19, 2019 08:40 am ET

New Research Coverage Highlights Turquoise Hill Resources, GDS HOLDINGS, AptarGroup, VBI Vaccines, Loral Space and Communications, and FEDNAT HOLDING CO — Consolidated Revenues, Company Growth, and Ex

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Turquoise Hill Resources Ltd. (NYSE:TRQ), GDS HOLDINGS (NASDAQ:GDS),...

Apr 18, 2019 05:00 pm ET

Aptar Announces New $350 Million Share Repurchase Authorization and Raises Quarterly Dividend

The Board of Directors of AptarGroup, Inc. (NYSE: ATR) yesterday authorized the repurchase of up to $350 million of the Company’s common stock. This new authorization replaces all previous authorizations. Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions. The Board also increased the quarterly cash dividend by 6% to $0.36 per share. The payment date is May 22, 2019, to stockholders of record as of May 1, 2019.

Mar 18, 2019 05:00 pm ET

Aptar Pharma’s Bidose Nasal Drug Delivery Device Approved by U.S. FDA for Breakthrough Treatment of Depression

Aptar Pharma, a leading drug delivery systems provider, is pleased to announce that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. This marks the first FDA approval and U.S. launch of a prescription drug using Aptar Pharma’s patented Bidose nasal spray delivery system.

Feb 20, 2019 05:00 pm ET

Aptar Reports Fourth Quarter and Annual Results

AptarGroup, Inc. (NYSE:ATR) today reported fourth quarter and annual results for 2018.

Feb 05, 2019 08:30 am ET

Aptar Joins the World Business Council for Sustainable Development

AptarGroup, Inc. (NYSE: ATR) announced today that it has joined nearly 200 forward-thinking companies as the newest member of the World Business Council for Sustainable Development (WBCSD).

Jan 23, 2019 07:35 am ET

Consolidated Research: 2019 Summary Expectations for Post, Westlake Chemical, Repligen, Weingarten Realty Investors, AptarGroup, and At Home Group — Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Post Holdings, Inc. (NYSE:POST), Westlake Chemical Corporation (NYSE:WLK),...

Jan 18, 2019 08:30 am ET

Aptar Signs the New Plastics Economy Global Commitment

AptarGroup, Inc. (NYSE: ATR) announced today that it has signed the New Plastics Economy Global Commitment and has joined forces with other businesses and governments committed to changing how we produce, use and reuse plastic.

Jan 17, 2019 05:00 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR) today declared a quarterly cash dividend of $0.34 per share. The payment date is February 20, 2019, to stockholders of record as of January 30, 2019.

Jan 09, 2019 05:00 pm ET

Aptar Announces Quarterly Conference Call and Annual Meeting Information

AptarGroup, Inc. (NYSE: ATR) announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.

Nov 16, 2018 09:00 am ET

Aptar Announces Price Increases

AptarGroup, Inc. (NYSE:ATR) announced today that it will increase prices between 5 and 10 percent for its beauty, personal care and home care products in North America. The price increases will take effect January 1, 2019 and will be in addition to any price adjustments related to import tariffs. The increases are necessary due to sustained significant cost inflation on raw materials, freight and other inputs.

Nov 01, 2018 05:00 pm ET

Aptar Reports Third Quarter Results

AptarGroup, Inc. (NYSE:ATR) today announced third quarter results.

Oct 25, 2018 01:15 pm ET

Aptar Appoints Chief Human Resources Officer

AptarGroup, Inc. (NYSE:ATR), announced today that Shiela Vinczeller was named Chief Human Resources Officer. Shiela will join Aptar on November 1, 2018 and will become a member of Aptar’s Executive Committee.

Oct 22, 2018 09:15 am ET

Analysis: Positioning to Benefit within Ligand Pharmaceuticals, AptarGroup, Unifirst, Universal, AutoZone, and Churchill Downs — Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), AptarGroup, Inc....

Oct 18, 2018 05:00 pm ET

Aptar Declares Quarterly Dividend

The Board of Directors of AptarGroup, Inc. (NYSE: ATR) today declared a quarterly cash dividend of $0.34 per share. The payment date is November 21, 2018, to stockholders of record as of October 31, 2018.

Oct 11, 2018 12:33 pm ET

Glenroy Inc. Selected as Exclusive Converter of Premade STANDCAP Pouch

Glenroy Inc., a converter and printer of flexible packaging for over 50 years, has been selected as the exclusive pouch converter of the new premade STANDCAP Pouch. Glenroy leverages proprietary VOLPAK converting technology to deliver the STANDCAP...

Sep 26, 2018 05:00 pm ET

Aptar Announces Change to Date for Third Quarter Conference Call

AptarGroup, Inc. (NYSE:ATR) today announced it has changed the date for its third quarter 2018 earnings conference call to Friday, November 2, 2018 at 8:00 a.m. Central Time. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page at www.aptar.com. Repla

Aug 27, 2018 05:00 pm ET

Aptar Completes Acquisition of CSP Technologies

AptarGroup, Inc. (NYSE:ATR) today announced it has completed the previously announced acquisition of CSP Technologies S.à r.l. (CSP Technologies), a leader in active packaging technology based on proprietary material science expertise.

Jul 26, 2018 06:39 pm ET

Aptar Reports Second Quarter Results; Announces Binding Offer to Acquire CSP Technologies, a Leader in Active Packaging Technology

AptarGroup, Inc. (NYSE:ATR) today announced second quarter operating results along with its binding offer to acquire CSP Technologies Parent S.A. (CSP Technologies), a leader in active packaging technology based on proprietary material science expertise.

Jul 18, 2018 05:00 pm ET

Aptar Raises Quarterly Dividend

The Board of Directors of AptarGroup, Inc. (NYSE: ATR) today increased the quarterly cash dividend by 6% to $0.34 per share. The payment date is August 22, 2018, to stockholders of record as of August 1, 2018. Stephan Tanda, President and CEO, commented, “Our dividend is an element of our balanced capital allocation strategy and with our strong balance sheet and confidence in our future, we are returning value to our shareholders with this increased dividend. This year will mark our 25th consecutive year of paying a higher annual divi

Jun 29, 2018 07:45 am ET

Report: Developing Opportunities within Newfield Exploration, Heritage Insurance, AptarGroup, Alder BioPharmaceuticals, TrueCar, and Aduro Biotech — Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Newfield Exploration Company (NYSE:NFX), Heritage Insurance Holdings, Inc....

Jun 21, 2018 05:00 pm ET

AptarGroup Releases Corporate Sustainability Report

AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing and sealing solutions, today released its 2017 Corporate Sustainability Report. The 2017 Sustainability Report highlights the robust sustainability initiatives that have been implemented across Aptar’s global operations.

Jun 19, 2018 08:00 am ET

Aptar Announces Leadership Appointments

AptarGroup, Inc. (NYSE: ATR) today announced the appointment of Gael Touya to President, Aptar Pharma effective September 1, 2018. Touya, who had been President, Aptar Food + Beverage since January of 2016, will continue to report to CEO Stephan Tanda. Touya succeeds Salim Haffar who has announced he will depart Aptar at the beginning of September to become CEO of a privately-held provider of outsourced pharmaceutical services.

May 30, 2018 08:00 am ET

Aptar Pharma and Propeller Health Partner to Develop Digital Medicine Platform Across Therapeutic Areas

Aptar Pharma, a leading provider of innovative drug delivery systems, and Propeller Health, a leading digital therapeutics company, announced plans to collaborate on the launch of a comprehensive platform to develop digital medicines for multiple therapeutic areas and diseases.

May 17, 2018 07:30 am ET

Investor Expectations to Drive Momentum within Sun Communities, Anheuser-Busch InBev SA/NV, New Media Investment Group, Teligent, AptarGroup, and Pinnacle Financial Partners — Discovering Underlying F

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Sun Communities, Inc. (NYSE:SUI), Anheuser-Busch InBev SA/NV (NYSE:BUD),...

May 02, 2018 08:00 am ET

Aptar Adds Capabilities to Better Serve the Growing Color Cosmetics Market; Acquires Reboul, an Established and Innovative Leader in Prestige Beauty Packaging

AptarGroup, Inc. (NYSE: ATR) today announced that as of May 1, 2018, it has acquired Reboul from Vacheron Industries SAS. Reboul is a French leader in the design and industrial production of high-quality metal components, metal-plastic sub-assemblies, next generation lipstick mechanisms, and complete color cosmetic packaging solutions.

Apr 26, 2018 05:00 pm ET

Aptar Reports First Quarter Results; Declares Quarterly Dividend

AptarGroup, Inc. (NYSE:ATR) today reported first quarter results and declared a quarterly dividend.

Apr 26, 2018 08:25 am ET

Detailed Research: Economic Perspectives on AptarGroup, Insteel Industries, Visteon, j2 Global, Winnebago Industries, and Valmont Industries — What Drives Growth in Today's Competitive Landscape

NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AptarGroup, Inc. (NYSE:ATR), Insteel Industries, Inc....

Apr 12, 2018 05:00 pm ET

Aptar Food + Beverage and Cheer Pack North America Partner to Launch a Premade No-Spill Spouted Pouch Solution

Aptar Food + Beverage, a global leader in innovative dispensing solutions for on-the-go drinks in the beverage market, and Cheer Pack North America (CPNA), a leader in premade spouted pouches, are partnering to launch a “No-Spill” Spouted Pouch solution for the North American market.

Feb 28, 2018 07:50 am ET

Detailed Research: Economic Perspectives on Golub Capital BDC, Cowen Group, Tabula Rasa Healthcare, Olympic Steel, Ingevity, and AptarGroup — What Drives Growth in Today's Competitive Landscape

NEW YORK, Feb. 28, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Golub Capital BDC, Inc. (NASDAQ:GBDC), Cowen...

Feb 12, 2018 05:33 pm ET

Aptar Reports Fourth Quarter and Annual Results; Announces Business Transformation Plan Details; Affirms Long-Term Financial Targets

AptarGroup, Inc. (NYSE:ATR) today reported fourth quarter and annual results for 2017. The Company also announced details of its business transformation plan and affirmed its long-term financial targets.

Feb 08, 2018 02:15 pm ET

AptarGroup and Adapt Pharma Donate NARCAN® Nasal Spray to Opioid Crisis Coalitions in Illinois

AptarGroup, a leading global provider of innovative drug delivery devices and consumer dispensing systems, and Adapt Pharma, a pharmaceutical company solely focused on expanding affordable access to NARCAN® (naloxone) Nasal Spray, today announced a joint donation of 4,000 doses of NARCAN® to Illinois Governor Bruce Rauner’s Opioid Overdose Prevention and Intervention Task Force, with another 1,000 doses scheduled to go to the McHenry County Substance Abuse Coalition Friday.

Jan 18, 2018 06:50 pm ET

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR) today declared a quarterly cash dividend of $0.32 per share. The payment date is February 21, 2018, to stockholders of record as of January 31, 2018.

Jan 18, 2018 06:14 pm ET

Aptar Announces Chairman King Harris to Retire in May; George Fotiades Elected as Incoming Chairman of the Board; Two New Directors Appointed

AptarGroup, Inc. (NYSE: ATR) Chairman of the Board King Harris will be retiring effective May 2, 2018, at the Annual Meeting of Stockholders. The company’s Board of Directors has elected current director George Fotiades to replace Harris as Chairman upon his retirement.

Jan 03, 2018 05:00 pm ET

AptarGroup Announces Quarterly Conference Call and Annual Meeting Information

AptarGroup, Inc. (NYSE: ATR) announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.

Jan 03, 2018 08:00 am ET

New Research: Key Drivers of Growth for Electro Scientific Industries, Illinois Tool Works, Magellan Midstream Partners, Visteon, Ingevity, and AptarGroup — Factors of Influence, Major Initiatives and

NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Electro Scientific Industries, Inc. (NASDAQ:ESIO), Illinois...

Oct 26, 2017 05:00 pm ET

AptarGroup Reports Third Quarter Results

AptarGroup, Inc. (NYSE: ATR), a global leader in innovative packaging technologies that build brand value, today announced its third quarter results.

Oct 19, 2017 05:00 pm ET

AptarGroup Declares Quarterly Dividend

The Board of Directors of AptarGroup, Inc. (NYSE: ATR) today declared a quarterly cash dividend of $0.32 per share. The payment date is November 22, 2017, to stockholders of record as of November 1, 2017.

Ad blocking detected

AptarGroup, Inc. (N:ATR)

Business Focus: Plastic Container & Packaging